<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19890394</article-id><article-id pub-id-type="publisher-id">09-PONE-RA-10355R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007733</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Geriatrics</subject><subject>Genetics and Genomics/Medical Genetics</subject><subject>Mathematics/Nonlinear Dynamics</subject><subject>Geriatrics/Geriatric Cardiology</subject></subj-group></article-categories><title-group><article-title>Reduced Physiological Complexity in Robust Elderly Adults with the APOE &#x003b5;4 Allele</article-title><alt-title alt-title-type="running-head">APOE and Heart-Rate Complexity</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Cheng</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tsai</surname><given-names>Shih-Jen</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Chen-Jee</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Albert C.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Divisions of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Psychiatry, Chu-Tung Veterans Hospital, Hsin-Chu County, Taiwan</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sorensen</surname><given-names>Thorkild I. A.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Institute of Preventive Medicine, Denmark</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>ccyang@physionet.org</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: SJT CJH ACY. Performed the experiments: DC. Analyzed the data: DC ACY. Contributed reagents/materials/analysis tools: SJT CJH ACY. Wrote the paper: DC ACY.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>5</day><month>11</month><year>2009</year></pub-date><volume>4</volume><issue>11</issue><elocation-id>e7733</elocation-id><history><date date-type="received"><day>14</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>2</day><month>10</month><year>2009</year></date></history><permissions><copyright-statement>Cheng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>It is unclear whether the loss of physiological complexity during the aging process is due to genetic variations. The APOE gene has been studied extensively in regard to its relationship with aging-associated medical illness. We hypothesize that diminished physiological complexity, as measured by heart rate variability, is influenced by polymorphisms in the APOE allele among elderly individuals.</p></sec><sec><title>Methodology/Principal Findings</title><p>A total of 102 robust, non-demented, elderly subjects with normal functions of daily activities participated in this study (97 males and 5 females, aged 79.2&#x000b1;4.4 years, range 72&#x02013;92 years). Among these individuals, the following two APOE genotypes were represented: &#x003b5;4 non-carriers (n&#x0200a;&#x0003d;&#x0200a;87, 85.3&#x00025;) and &#x003b5;4 carriers (n&#x0200a;&#x0003d;&#x0200a;15, 14.7&#x00025;). Multi-scale entropy (MSE), an analysis used in quantifying complexity for nonlinear time series, was employed to analyze heart-rate dynamics. Reduced physiological complexity, as measured by MSE, was significantly associated with the presence of the APOE &#x003b5;4 allele in healthy elderly subjects, as compared to APOE &#x003b5;4 allele non-carriers (24.6&#x000b1;5.5 versus 28.9&#x000b1;5.2, F&#x0200a;&#x0003d;&#x0200a;9.429, <italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.003, respectively).</p></sec><sec><title>Conclusions/Significance</title><p>This finding suggests a role for the APOE gene in the diminished physiological complexity seen in elderly populations.</p></sec></abstract><counts><page-count count="6"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Biologically, the physiological output of the human body emerges from interactions among a variety of factors, ranging from genes to organs to the environment <xref ref-type="bibr" rid="pone.0007733-Park1">&#x0005b;1&#x0005d;</xref>. These interactions, under healthy conditions, are essential for responses to environmental stress and are evident in both behavioral and physiological complexity, such as daily activities, heart rate, blood pressure, and brain electrical activities. In contrast, aging and illness are associated with degraded and/or decoupled regulatory networks and often result in the generation of less complex outputs <xref ref-type="bibr" rid="pone.0007733-Goldberger1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>. The loss of complexity is therefore, to a large extent, the hallmark of illness and the aging process <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Vaillancourt1">&#x0005b;4&#x0005d;</xref>. This reduced complexity can be quantified both behaviorally <xref ref-type="bibr" rid="pone.0007733-Vaillancourt1">&#x0005b;4&#x0005d;</xref> and physiologically, such as through analysis of heart rate variability (HRV) <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>. However, despite a growing body of clinical and basic science research of applying complexity theory in aging and illness <xref ref-type="bibr" rid="pone.0007733-Goldberger1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Vaillancourt1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Kirkwood1">&#x0005b;5&#x0005d;</xref>, the relationship between the loss of such complexity and a genetic predisposition is still unclear.</p><p>The apolipoprotein-E (APOE) gene has been studied extensively in regard to its relationship to aging-associated medical illness, including cardiovascular disease <xref ref-type="bibr" rid="pone.0007733-Utermann1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Wilson1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Stengard1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Rosvall1">&#x0005b;9&#x0005d;</xref>, geriatric cognitive decline <xref ref-type="bibr" rid="pone.0007733-Christensen1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Reed1">&#x0005b;11&#x0005d;</xref>, and late-onset Alzheimer's disease <xref ref-type="bibr" rid="pone.0007733-Corder1">&#x0005b;12&#x0005d;</xref>. The impact of the APOE polymorphism on the increased risk of a variety of medical illnesses might lead to a reduced life span and decreased adaptability of affected individuals to stress. These separate lines of evidence lead to our hypothesis that variants of the APOE gene (e.g., the &#x003b5;4 allele) may potentially reduce physiological complexity in an affected individual, even before the onset of certain medical illness related to APOE variants. Therefore, in the present study, we applied a multiscale entropy (MSE) analysis to examine effects of the APOE genotypes on heart rate dynamics in a cohort of robust elderly adults.</p></sec><sec id="s2"><title>Results</title><p>Descriptive statistics are summarized in <xref ref-type="table" rid="pone-0007733-t001">Table 1</xref>. Clinical characteristics were not different between the APOE &#x003b5;4-negative and &#x003b5;4-positive groups, except that the gender distribution was unbalanced between two groups (male, &#x00025;: 97.7 vs. 80.0, <italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.02, respectively). A comparison of representative interbeat interval time series and MSE analysis between an APOE &#x003b5;4-negative and an APOE &#x003b5;4-positive subject is shown in <xref ref-type="fig" rid="pone-0007733-g001">Figure 1</xref>. There were no significant differences in conventional HRV measures between two groups (<xref ref-type="table" rid="pone-0007733-t002">Table 2</xref>). We also found no significant correlations between the MSE and conventional HRV indices. Significantly lower values of MSE were found in the &#x003b5;4-positive group compared to &#x003b5;4-negative group (24.6&#x000b1;5.5 vs. 28.9&#x000b1;5.2, F&#x0200a;&#x0003d;&#x0200a;9.429, <italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.003, respectively). No significant MSE by ANCOVA covarying for age or clinical parameters interaction effect was found. <xref ref-type="fig" rid="pone-0007733-g002">Figure 2</xref> shows the comparison of the MSE analysis for the entire study cohort by the APOE &#x003b5;4 genotype at different time scales. For scales ranging from 3 to 13 (equal to interbeat interval time series of 10 to 40 heartbeats), the sample entropy values were significantly lower (<italic>t</italic>-test, <italic>p</italic>&#x0003c;0.01) for the group of APOE &#x003b5;4-positive, as compared to the group without the APOE &#x003b5;4 allele.</p><fig id="pone-0007733-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007733.g001</object-id><label>Figure 1</label><caption><title>A comparison of a representative interbeat interval time series and analysis of multiscale entropy (MSE) between an APOE &#x003b5;4-negative subject (top panels) and an APOE &#x003b5;4-positive subject (bottom panels).</title><p>Time series length is 30 minutes. The APOE &#x003b5;4-negative subject showed multiscale organizations in fluctuations of interbeat intervals, whereas a relatively monotonic oscillation was seen in the interbeat interval time series obtained from an APOE &#x003b5;4-positive subject. By considering the impact of scale on entropy calculations, the sample entropy values for the APOE &#x003b5;4-negative subject is higher than that for the APOE &#x003b5;4-positive subject for scales larger than two. Of note, the sum of MSE from scale factor 1 to 20 was 28.3 for the APOE &#x003b5;4-negative subject and 17.3 for the APOE &#x003b5;4-positive subject.</p></caption><graphic xlink:href="pone.0007733.g001"/></fig><fig id="pone-0007733-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007733.g002</object-id><label>Figure 2</label><caption><title>Multiscale entropy analysis by APOE &#x003b5;4 genotype.</title><p>Multiscale entropy was derived from two-hours of interbeat interval time series. Symbols represent mean values of entropy for each group and the bars represent the standard error. Parameters of sample entropy calculation are m&#x0200a;&#x0003d;&#x0200a;2 and r&#x0200a;&#x0003d;&#x0200a;0.15. The sample entropy values for subjects with APOE &#x003b5;4 allele are significantly lower (<italic>p</italic>&#x0003c;0.01) on scales between 3 and 13, which are equal to oscillations at period around 10 to 40 heartbeats. <italic>p</italic> values were computed using Student's <italic>t</italic>-test at each scale factor.</p></caption><graphic xlink:href="pone.0007733.g002"/></fig><table-wrap id="pone-0007733-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007733.t001</object-id><label>Table 1</label><caption><title>Demographics and clinical characteristics.</title></caption><alternatives><graphic id="pone-0007733-t001-1" xlink:href="pone.0007733.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Characteristics</td><td align="left" rowspan="1" colspan="1">APOE &#x003b5;4-negative N&#x0200a;&#x0003d;&#x0200a;87</td><td align="left" rowspan="1" colspan="1">APOE &#x003b5;4-positive N&#x0200a;&#x0003d;&#x0200a;15</td><td align="left" rowspan="1" colspan="1"><italic>t or &#x003c7;<sup>2</sup></italic></td><td align="left" rowspan="1" colspan="1"><italic>p</italic></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, year</td><td align="left" rowspan="1" colspan="1">79.1&#x000b1;4.4</td><td align="left" rowspan="1" colspan="1">79.4&#x000b1;4.2</td><td align="left" rowspan="1" colspan="1">&#x02212;0.222</td><td align="left" rowspan="1" colspan="1">0.825</td></tr><tr><td align="left" rowspan="1" colspan="1">Male gender, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">85 (97.7)</td><td align="left" rowspan="1" colspan="1">12 (80.0)</td><td align="left" rowspan="1" colspan="1">5.22</td><td align="left" rowspan="1" colspan="1">0.022</td></tr><tr><td align="left" rowspan="1" colspan="1">Education, year</td><td align="left" rowspan="1" colspan="1">7.2&#x000b1;4.3</td><td align="left" rowspan="1" colspan="1">7.1&#x000b1;5.5</td><td align="left" rowspan="1" colspan="1">0.106</td><td align="left" rowspan="1" colspan="1">0.916</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup></td><td align="left" rowspan="1" colspan="1">23.8&#x000b1;3.1</td><td align="left" rowspan="1" colspan="1">24.8&#x000b1;3.0</td><td align="left" rowspan="1" colspan="1">&#x02212;1.068</td><td align="left" rowspan="1" colspan="1">0.289</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">44 (50.6)</td><td align="left" rowspan="1" colspan="1">9 (60.0)</td><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">0.689</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">10 (11.5)</td><td align="left" rowspan="1" colspan="1">1 (6.7)</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.920</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">6 (6.9)</td><td align="left" rowspan="1" colspan="1">1 (6.7)</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">0.603</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smoker, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">22 (25.3)</td><td align="left" rowspan="1" colspan="1">2 (13.3)</td><td align="left" rowspan="1" colspan="1">0.46</td><td align="left" rowspan="1" colspan="1">0.498</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure, mmHg</td><td align="left" rowspan="1" colspan="1">145&#x000b1;21</td><td align="left" rowspan="1" colspan="1">141&#x000b1;12</td><td align="left" rowspan="1" colspan="1">0.633</td><td align="left" rowspan="1" colspan="1">0.528</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure, mmHg</td><td align="left" rowspan="1" colspan="1">78&#x000b1;11</td><td align="left" rowspan="1" colspan="1">71&#x000b1;11</td><td align="left" rowspan="1" colspan="1">1.738</td><td align="left" rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" rowspan="1" colspan="1">White blood cell count, 10<sup>3</sup>/mm<sup>3</sup></td><td align="left" rowspan="1" colspan="1">7.3&#x000b1;2.9</td><td align="left" rowspan="1" colspan="1">7.5&#x000b1;2.3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.151</td><td align="left" rowspan="1" colspan="1">0.881</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin, mg/dL</td><td align="left" rowspan="1" colspan="1">14.4&#x000b1;1.8</td><td align="left" rowspan="1" colspan="1">14.7&#x000b1;1.5</td><td align="left" rowspan="1" colspan="1">&#x02212;0.591</td><td align="left" rowspan="1" colspan="1">0.556</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting glucose, mg/dL</td><td align="left" rowspan="1" colspan="1">89.7&#x000b1;15.8</td><td align="left" rowspan="1" colspan="1">89.0&#x000b1;13.1</td><td align="left" rowspan="1" colspan="1">0.136</td><td align="left" rowspan="1" colspan="1">0.892</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol, mg/dL</td><td align="left" rowspan="1" colspan="1">194.7&#x000b1;48.6</td><td align="left" rowspan="1" colspan="1">182.2&#x000b1;19.3</td><td align="left" rowspan="1" colspan="1">0.839</td><td align="left" rowspan="1" colspan="1">0.404</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides, mg/dL</td><td align="left" rowspan="1" colspan="1">120.5&#x000b1;64.9</td><td align="left" rowspan="1" colspan="1">112.2&#x000b1;56.8</td><td align="left" rowspan="1" colspan="1">0.4031</td><td align="left" rowspan="1" colspan="1">0.688</td></tr><tr><td align="left" rowspan="1" colspan="1">Mini-mental state examination, score (0&#x02013;30)</td><td align="left" rowspan="1" colspan="1">27.9&#x000b1;2.1</td><td align="left" rowspan="1" colspan="1">27.3&#x000b1;2.0</td><td align="left" rowspan="1" colspan="1">0.974</td><td align="left" rowspan="1" colspan="1">0.332</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>Values are mean &#x000b1; standard deviation unless otherwise noted.</p></fn><fn id="nt102"><label/><p>Categorical data are compared by chi-square tests, two tailed; all other <italic>p</italic> values are by Student's <italic>t</italic> test, two tailed.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0007733-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007733.t002</object-id><label>Table 2</label><caption><title>Heart-rate variability characteristics.</title></caption><alternatives><graphic id="pone-0007733-t002-2" xlink:href="pone.0007733.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Variable</td><td align="left" rowspan="1" colspan="1">APOE &#x003b5;4-negative N&#x0200a;&#x0003d;&#x0200a;87</td><td align="left" rowspan="1" colspan="1">APOE &#x003b5;4-positive N&#x0200a;&#x0003d;&#x0200a;15</td><td align="left" rowspan="1" colspan="1"><italic>F</italic></td><td align="left" rowspan="1" colspan="1"><italic>p</italic></td></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1"><bold>Time Domain Measure</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Mean heart rate, beat/min</td><td align="left" rowspan="1" colspan="1">77.9&#x000b1;16.0</td><td align="left" rowspan="1" colspan="1">80.9&#x000b1;16.6</td><td align="left" rowspan="1" colspan="1">0.454</td><td align="left" rowspan="1" colspan="1">0.502</td></tr><tr><td align="left" rowspan="1" colspan="1">Standard deviation of normal interbeat intervals, ms</td><td align="left" rowspan="1" colspan="1">70.3&#x000b1;32.4</td><td align="left" rowspan="1" colspan="1">72.1&#x000b1;27.8</td><td align="left" rowspan="1" colspan="1">0.027</td><td align="left" rowspan="1" colspan="1">0.871</td></tr><tr><td align="left" rowspan="1" colspan="1">Root mean square successive difference between adjacent normal interbeat intervals, ms</td><td align="left" rowspan="1" colspan="1">35.0&#x000b1;25.1</td><td align="left" rowspan="1" colspan="1">31.6&#x000b1;17.5</td><td align="left" rowspan="1" colspan="1">0.284</td><td align="left" rowspan="1" colspan="1">0.595</td></tr><tr><td align="left" rowspan="1" colspan="1">Percentage of adjacent normal interbeat intervals that varied by greater than 50 ms, &#x00025;</td><td align="left" rowspan="1" colspan="1">12.7&#x000b1;18.0</td><td align="left" rowspan="1" colspan="1">8.0&#x000b1;8.8</td><td align="left" rowspan="1" colspan="1">0.991</td><td align="left" rowspan="1" colspan="1">0.322</td></tr><tr><td colspan="5" align="left" rowspan="1"><bold>Frequency Domain Measure</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Very-low-frequency power, ln(ms<sup>2</sup>/Hz)</td><td align="left" rowspan="1" colspan="1">7.94&#x000b1;0.88</td><td align="left" rowspan="1" colspan="1">7.88&#x000b1;0.93</td><td align="left" rowspan="1" colspan="1">0.079</td><td align="left" rowspan="1" colspan="1">0.779</td></tr><tr><td align="left" rowspan="1" colspan="1">Low-frequency power, ln(ms<sup>2</sup>/Hz)</td><td align="left" rowspan="1" colspan="1">6.41&#x000b1;1.07</td><td align="left" rowspan="1" colspan="1">6.21&#x000b1;0.94</td><td align="left" rowspan="1" colspan="1">0.491</td><td align="left" rowspan="1" colspan="1">0.485</td></tr><tr><td align="left" rowspan="1" colspan="1">High-frequency power, ln(ms<sup>2</sup>/Hz)</td><td align="left" rowspan="1" colspan="1">6.13&#x000b1;1.40</td><td align="left" rowspan="1" colspan="1">6.02&#x000b1;1.14</td><td align="left" rowspan="1" colspan="1">0.102</td><td align="left" rowspan="1" colspan="1">0.750</td></tr><tr><td align="left" rowspan="1" colspan="1">Low-frequency/high-frequency power, ln(ms<sup>2</sup>/Hz)</td><td align="left" rowspan="1" colspan="1">2.05&#x000b1;1.35</td><td align="left" rowspan="1" colspan="1">1.87&#x000b1;1.25</td><td align="left" rowspan="1" colspan="1">0.206</td><td align="left" rowspan="1" colspan="1">0.651</td></tr><tr><td colspan="5" align="left" rowspan="1"><bold>Complexity Measure</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Multiscale entropy, sum of sample entropy from scale factor 1 to 20</td><td align="left" rowspan="1" colspan="1">28.9&#x000b1;5.2</td><td align="left" rowspan="1" colspan="1">24.6&#x000b1;5.5</td><td align="left" rowspan="1" colspan="1">9.429</td><td align="left" rowspan="1" colspan="1">0.003</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>Values are mean &#x000b1; standard deviation unless otherwise noted.</p></fn><fn id="nt104"><label/><p>Power spectral estimates were log transformed due to skewed distributions. F ratios from analyses of covariance, controlling for age and clinical parameters.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3"><title>Discussion</title><p>Consistent with our hypothesis, the key finding of this study is that reduced physiological complexity, as measured by multi-scale entropy analysis, is associated with the APOE &#x003b5;4 allele in this robust, aged population. The concept of loss of physiological complexity in illness and during the aging process has been hypothesized by several literature sources <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Vaillancourt1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Peng1">&#x0005b;13&#x0005d;</xref>. Degeneration of the control mechanisms by illness and aging may lead to a breakdown of coupling between physiological components and thus result in the loss of complexity in heart rate dynamics <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>. Moreover, the lack of associations between MSE and other time-frequency HRV measures indicates that MSE contains new information (complexity) which was not quantified by conventional HRV indices. The findings of a relationship between the APOE &#x003b5;4 allele and reduced physiological complexity at different time scales suggest that variants of the APOE gene may affect the integrity of the physiological system during the aging process. While the exact mechanism of how the APOE &#x003b5;4 allele affects physiological functions is unclear, degeneration of overall brain functions associated with the APOE &#x003b5;4 allele <xref ref-type="bibr" rid="pone.0007733-Jak1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Isoniemi1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Enzinger1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Geroldi1">&#x0005b;17&#x0005d;</xref>, which further results in decoupling between physiological control systems, is a possible mechanism underlying the association between APOE &#x003b5;4 allele and reduced physiological complexity.</p><p>The present study employed a nonlinear method adapted from complexity theory, multi-scale entropy, to detect changes in physiological complexity in an aged population. Cardiovascular signals are largely analyzed using traditional time and frequency domain measures. However, such measures fail to account for important properties related to multi-scale organization and nonequilibrium dynamics <xref ref-type="bibr" rid="pone.0007733-Goldberger2">&#x0005b;3&#x0005d;</xref>. The complementary role of complexity analysis is, therefore, an important tool to quantify the nonlinear properties of physiological signals. Of note, reduced complexity (e.g., fractal properties) have been implicated in the risk of fatal cardiac arrhythmia, increased mortality, or poor prognosis in cardiovascular diseases <xref ref-type="bibr" rid="pone.0007733-Ho1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Chiu1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Makikallio1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Tapanainen1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Tsuji1">&#x0005b;22&#x0005d;</xref>. Our findings of a relationship between reduced physiological complexity and the APOE &#x003b5;4 allele is in line with the observation that APOE &#x003b5;4 increases the risk of cardiovascular events in the long run <xref ref-type="bibr" rid="pone.0007733-Wilson1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Stengard1">&#x0005b;8&#x0005d;</xref>. Limited studies have shown procedures/exercise (e.g., meditation or Tai-Chi exercise) that are able to increase vagal tone could have protective effect on heart functions <xref ref-type="bibr" rid="pone.0007733-Yeh1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Yeh2">&#x0005b;24&#x0005d;</xref>. However, it's not clear whether these preventive means also alter the physiological complexity. Therefore, further research is warranted to examine if an appropriate treatment/prevention could compensate the adverse impact of APOE &#x003b5;4 allele on physiologic functions.</p><p>There are limitations to this study. First, an evaluation of cardiovascular function was not done and, thus, we cannot exclude the possibility that subjects with this genetic finding also had occult cardiovascular disease. Second, the possibility of selection bias cannot be excluded due to the relatively small sample of subjects and biased gender distribution towards the male gender (majority of study subjects were veterans). Prior reports have shown that gender may modulate the association between APOE gene and related neuropathology <xref ref-type="bibr" rid="pone.0007733-Rosvall1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Ghebremedhin1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Mortensen1">&#x0005b;26&#x0005d;</xref>, and therefore may potentially affect the result of HRV analysis. Gender effect should be factored in the future study. Third, as the study design was cross-sectional, we cannot directly evaluate the long-term impact of the APOE polymorphism on the physiological complexity and incidence of cardiovascular diseases. A prospective study with a larger population should be done to address this issue. Finally, interbeat interval time series obtained from this aged population also posed a challenge to HRV analysis as ectopic heartbeats or cardiac arrhythmia (e.g., atrial fibrillation) are more common in elderly populations. However, the subjects in the present study were generally healthy and had no severe cardiac arrhythmia, thus permitting the feasibility of applying HRV analysis to these aged individuals.</p><p>In conclusion, reduced physiological complexity, as measured by complexity analysis, was significantly associated with the presence of the APOE &#x003b5;4 allele in healthy elderly subjects. This observation may provide implications for understanding the role of genetic predisposition in physiological aging. Further large-scale research is warranted to investigate the interactions between genes, physiological functioning, and the environment in the elderly.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Ethics Statement</title><p>All subjects gave written informed consent before commencement of the study. The protocol was approved by the Institutional Review Board of the Taipei Veterans General Hospital.</p></sec><sec id="s4b"><title>Study Sample</title><p>A total of 184 elderly Chinese-Han elderly volunteers were screened from a public veterans housing (N&#x0200a;&#x0003d;&#x0200a;161) and a local elderly housing (N&#x0200a;&#x0003d;&#x0200a;22) in the community. Of these subjects, 113 were successfully contacted for ambulatory electrocardiogram (ECG) monitoring. Each subject's history of medical disease, psychiatric illness, and medication use was evaluated carefully. Evaluation of the psychiatric history and of cognitive functioning was conducted by a psychiatrist. In addition, each subject underwent a basic physical examination and laboratory testing in order to gather data on clinical parameters. Subjects were screened and excluded if they had acute or major medical diseases (e.g., malignancy, heart failure, or infection), severe cardiac arrhythmia or frequent ectopic heartbeats, dementia (defined by clinical dementia rating scale &#x0003e;0.5), or a history of mental illness. Subjects were also excluded if they took medication with documented effects on the autonomic nervous system (e.g., beta-blockers). Of these 113 subjects, eleven were further excluded based on the above criteria. The final study sample consisted of 102 robust, non-demented elderly subjects with normal functions of daily activities (97 males and 5 females, aged 79.2&#x000b1;4.4 years, range 72&#x02013;92 years).</p></sec><sec id="s4c"><title>Laboratory Methods and ECG Monitoring</title><p>APOE genotyping was determined using PCR-RFLP, according to the procedure reported previously <xref ref-type="bibr" rid="pone.0007733-Wenham1">&#x0005b;27&#x0005d;</xref>. The studies of APOE and cognitive functions as well as heart rate variability and cognitive functions has been reported elsewhere <xref ref-type="bibr" rid="pone.0007733-Tsai1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Yang1">&#x0005b;29&#x0005d;</xref>. Of the 102 subjects, there were four genotypes: &#x003b5;2/&#x003b5;2 (n&#x0200a;&#x0003d;&#x0200a;1, 1.0&#x00025;), &#x003b5;2/&#x003b5;3 (n&#x0200a;&#x0003d;&#x0200a;14, 13.7&#x00025;), &#x003b5;3/&#x003b5;3 (n&#x0200a;&#x0003d;&#x0200a;72, 70.6&#x00025;), and &#x003b5;3/&#x003b5;4 (n&#x0200a;&#x0003d;&#x0200a;15, 14.7&#x00025;). When the sample was stratified according to the presence of the &#x003b5;4 allele, 15 (14.7&#x00025;) were &#x003b5;4 carriers compared with 87 (85.3&#x00025;) non-&#x003b5;4 carriers. The frequency of &#x003b5;4 allele was comparable with prior studies worldwide based on the community sample (7.9&#x00025;&#x02013;16.5&#x00025;) <xref ref-type="bibr" rid="pone.0007733-Liu1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Hong1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Hallman1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Myers1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Slooter1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Kuusisto1">&#x0005b;35&#x0005d;</xref>. These subjects then underwent two-hour electrocardiogram (ECG) monitoring using a Holter monitor (MyECG E3-80 Portable Recorder, Microstar Inc., Taipei, Taiwan). All ECG monitoring took place in the daytime and participants were asked to stay in the resting state and to avoid smoking and drinking alcoholic beverages before the experimental procedures.</p><p>The Holter device continuously recorded three channels of ECG signals at a sampling rate of 250 Hz. The ECG signals were then processed and analyzed by an open source of HRV algorithms <xref ref-type="bibr" rid="pone.0007733-Goldberger3">&#x0005b;36&#x0005d;</xref>. Briefly, after detecting the QRS complex on ECG by locating the R apex, the interbeat interval data was automatically calculated as the time interval between two consecutive R peaks (R-R interval). All beat annotations were carefully checked to avoid erroneous detections or missed beats.</p></sec><sec id="s4d"><title>Analysis of Conventional Heart-Rate Variability</title><p>Conventional time and frequency domain HRV measures are employed. Time domain measures of HRV include the mean heart rate and standard deviation of the normal interbeat intervals (SDNN), the root mean square successive difference between adjacent normal interbeat intervals (RMSSD), and the percentage of adjacent intervals that varied by greater than 50 ms (pNN50) <xref ref-type="bibr" rid="pone.0007733-Mietus1">&#x0005b;37&#x0005d;</xref>. Spectral HRV measures <xref ref-type="bibr" rid="pone.0007733-TaskForce1">&#x0005b;38&#x0005d;</xref> include high-frequency power (0.15&#x02013;0.40 Hz), low-frequency power (0.04&#x02013;0.15 Hz), and very-low-frequency power (0.003&#x02013;0.04 Hz). Briefly, the RMSSD and pNN50 measure the short-term variation of interbeat intervals, which is mainly modulated by parasympathetic innervation <xref ref-type="bibr" rid="pone.0007733-Goldberger4">&#x0005b;39&#x0005d;</xref>. Low-frequency power is suggested to be modulated by both sympathetic and parasympathetic activities, whereas high-frequency power is mainly modulated by parasympathetic activity <xref ref-type="bibr" rid="pone.0007733-Katona1">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Pomeranz1">&#x0005b;41&#x0005d;</xref>. The low-frequency/high-frequency ratio was computed as a measure of the sympathovagal balance toward sympathetic activity <xref ref-type="bibr" rid="pone.0007733-TaskForce1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Malliani1">&#x0005b;42&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Analysis of Physiological Complexity</title><p>Physiological signals under healthy conditions typically exhibit multi-scale variability, long-range correlations, and non-linearity <xref ref-type="bibr" rid="pone.0007733-BarYam1">&#x0005b;43&#x0005d;</xref>. Traditional complexity measurements are based on the concept of entropy which quantifes the regularity (orderliness) of a time series. Entropy increases with the degree of disorder and is maximum for completely random systems. However, an increase in entropy may not always be associated with an increase in dynamical complexity. For instance, a randomized surrogate time series has higher entropy than the original time series, despite the process of generating the surrogate data destroys correlations and degrades the information content of the original signal. A biologically meaningful complexity measure has been proposed by measuring the entropy over multiple time scales inherent in physiologic signals, termed multiscale entropy (MSE) <xref ref-type="bibr" rid="pone.0007733-Costa1">&#x0005b;44&#x0005d;</xref>. MSE was computed over the interbeat interval data using publicly available algorithms from the PhysioNet <xref ref-type="bibr" rid="pone.0007733-Goldberger3">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Costa1">&#x0005b;44&#x0005d;</xref>. The algorithm of MSE is as follows: Given a one-dimensional discrete time series, {x<sub>1</sub>,&#x02026;, x<sub>i</sub>;&#x02026;,x<sub>N</sub>}, we construct consecutive coarse-grained time series, {y<sup>(&#x003c4;)</sup>}, determined by the scale factor, &#x003c4;, according to the equation: <inline-formula><inline-graphic xlink:href="pone.0007733.e001.jpg" mimetype="image"/></inline-formula>, 1&#x02264;j&#x02264;N/&#x003c4;. The length of each coarse-grained time series is equal to the length of the original time series divided by the scale factor, &#x003c4;. For scale one, the time series is simply the original time series. We then calculate an entropy measure (sample entropy) for each coarse-grained time series and plot it as a function of the scale factor&#x003c4;<italic>&#x003c4;</italic>. The procedure and calculation of the MSE is summerized as following three steps: 1) construction of coarse-grained time series, 2) quantification of the sample entropy of each coarse-grained time series, and 3) summation of the sample entropy values over a range of scales. In the present study, sample entropy was calculated using a pattern length (m) of 2 and a similarity factor (r) of 0.15. The sum of sample entropy over all scale factors from 1 to 20 was computed for each subject and used to represent MSE in subsequent analyses. Of note, to reduce the non-stationarity beyond the maximum time scale detected by the MSE method (i.e., at scale 20, MSE can detect oscillation at the maximum of time period covering 61 heartbeats), interbeat interval time series was pre-detrended using the empirical mode decomposition method <xref ref-type="bibr" rid="pone.0007733-Huang1">&#x0005b;45&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Wu1">&#x0005b;46&#x0005d;</xref>.</p></sec><sec id="s4f"><title>Statistical Analysis</title><p>We performed allele and genotype frequency and Hardy-Weinberg equilibrium tests for each APOE genotype. Chi-square tests were used to compare categorical variables. Student's <italic>t</italic>-test was used to test for differences in demographic and clinical measures between APOE &#x003b5;4 carriers and non-carriers. Analysis of covariance (ANCOVA) was employed to determine group differences for the HRV variables, controlling for age and clinical parameters effects in this study sample. Partial correlation analysis was applied, controlling for age and clinical measures, to determine the associations between conventional HRV indices and the MSE measure. A more rigorous p-value of less than 0.01 (two-tailed) for the nature of association study was required for statistical significance. Based on prior literatures of applying MSE in healthy elderly subjects <xref ref-type="bibr" rid="pone.0007733-Costa1">&#x0005b;44&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007733-Costa2">&#x0005b;47&#x0005d;</xref>, we estimated the total sample size to be at least 94 by assuming power of 80&#x00025;, 1&#x00025; significance level, minimum expected difference of 5 and estimated standard deviation of 5.</p></sec></sec></body><back><ack><p>The authors wish to thank Shan-Ing Chen, Cheng-Ju Wang, and Meng-Wei Wang for their excellent technical assistance and Dr. Chung-Kang Peng (Margret and H. A. Rey Institute for Nonlinear Dynamics in Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School) for valuable discussions.</p></ack><ref-list><title>References</title><ref id="pone.0007733-Park1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O'Neill</surname><given-names>MS</given-names></name><name><surname>Wright</surname><given-names>RO</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><etal/></person-group><year>2006</year><article-title>HFE genotype, particulate air pollution, and heart rate variability: a gene-environment interaction.</article-title><source>Circulation</source><volume>114</volume><fpage>2798</fpage><lpage>2805</lpage><pub-id pub-id-type="pmid">17145987</pub-id></mixed-citation></ref><ref id="pone.0007733-Goldberger1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname><given-names>AL</given-names></name><name><surname>Amaral</surname><given-names>LA</given-names></name><name><surname>Hausdorff</surname><given-names>JM</given-names></name><name><surname>Ivanov</surname><given-names>P</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name><etal/></person-group><year>2002</year><article-title>Fractal dynamics in physiology: alterations with disease and aging.</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><issue>Suppl 1</issue><fpage>2466</fpage><lpage>2472</lpage><pub-id pub-id-type="pmid">11875196</pub-id></mixed-citation></ref><ref id="pone.0007733-Goldberger2"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname><given-names>AL</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name><name><surname>Lipsitz</surname><given-names>LA</given-names></name></person-group><year>2002</year><article-title>What is physiologic complexity and how does it change with aging and disease?</article-title><source>Neurobiol Aging</source><volume>23</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11755014</pub-id></mixed-citation></ref><ref id="pone.0007733-Vaillancourt1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaillancourt</surname><given-names>DE</given-names></name><name><surname>Newell</surname><given-names>KM</given-names></name></person-group><year>2002</year><article-title>Changing complexity in human behavior and physiology through aging and disease.</article-title><source>Neurobiol Aging</source><volume>23</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11755010</pub-id></mixed-citation></ref><ref id="pone.0007733-Kirkwood1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkwood</surname><given-names>TB</given-names></name></person-group><year>2002</year><article-title>Changing complexity in aging: a metric not an hypothesis.</article-title><source>Neurobiol Aging</source><volume>23</volume><fpage>21</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">11755013</pub-id></mixed-citation></ref><ref id="pone.0007733-Utermann1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utermann</surname><given-names>G</given-names></name><name><surname>Hardewig</surname><given-names>A</given-names></name><name><surname>Zimmer</surname><given-names>F</given-names></name></person-group><year>1984</year><article-title>Apolipoprotein E phenotypes in patients with myocardial infarction.</article-title><source>Hum Genet</source><volume>65</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">6698548</pub-id></mixed-citation></ref><ref id="pone.0007733-Wilson1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Myers</surname><given-names>RH</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Ordovas</surname><given-names>JM</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><etal/></person-group><year>1994</year><article-title>Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.</article-title><source>JAMA</source><volume>272</volume><fpage>1666</fpage><lpage>1671</lpage><pub-id pub-id-type="pmid">7966894</pub-id></mixed-citation></ref><ref id="pone.0007733-Stengard1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stengard</surname><given-names>JH</given-names></name><name><surname>Zerba</surname><given-names>KE</given-names></name><name><surname>Pekkanen</surname><given-names>J</given-names></name><name><surname>Ehnholm</surname><given-names>C</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name><etal/></person-group><year>1995</year><article-title>Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men.</article-title><source>Circulation</source><volume>91</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">7805227</pub-id></mixed-citation></ref><ref id="pone.0007733-Rosvall1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosvall</surname><given-names>L</given-names></name><name><surname>Rizzuto</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>HX</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Graff</surname><given-names>C</given-names></name><etal/></person-group><year>2009</year><article-title>APOE-related mortality: Effect of dementia, cardiovascular disease and gender.</article-title><source>Neurobiol Aging</source><volume>30</volume><fpage>1545</fpage><lpage>1551</lpage><pub-id pub-id-type="pmid">18237822</pub-id></mixed-citation></ref><ref id="pone.0007733-Christensen1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Batterham</surname><given-names>PJ</given-names></name><name><surname>Mackinnon</surname><given-names>AJ</given-names></name><name><surname>Jorm</surname><given-names>AF</given-names></name><name><surname>Mack</surname><given-names>HA</given-names></name><etal/></person-group><year>2008</year><article-title>The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample.</article-title><source>BMC Geriatr</source><volume>8</volume><fpage>14</fpage><pub-id pub-id-type="pmid">18620605</pub-id></mixed-citation></ref><ref id="pone.0007733-Reed1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>T</given-names></name><name><surname>Carmelli</surname><given-names>D</given-names></name><name><surname>Swan</surname><given-names>GE</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><name><surname>Welsh</surname><given-names>KA</given-names></name><etal/></person-group><year>1994</year><article-title>Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.</article-title><source>Arch Neurol</source><volume>51</volume><fpage>1189</fpage><lpage>1192</lpage><pub-id pub-id-type="pmid">7986172</pub-id></mixed-citation></ref><ref id="pone.0007733-Corder1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname><given-names>EH</given-names></name><name><surname>Saunders</surname><given-names>AM</given-names></name><name><surname>Strittmatter</surname><given-names>WJ</given-names></name><name><surname>Schmechel</surname><given-names>DE</given-names></name><name><surname>Gaskell</surname><given-names>PC</given-names></name><etal/></person-group><year>1993</year><article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.</article-title><source>Science</source><volume>261</volume><fpage>921</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">8346443</pub-id></mixed-citation></ref><ref id="pone.0007733-Peng1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>CK</given-names></name><name><surname>Buldyrev</surname><given-names>SV</given-names></name><name><surname>Hausdorff</surname><given-names>JM</given-names></name><name><surname>Havlin</surname><given-names>S</given-names></name><name><surname>Mietus</surname><given-names>JE</given-names></name><etal/></person-group><year>1994</year><article-title>Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system.</article-title><source>Integr Physiol Behav Sci</source><volume>29</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">7811648</pub-id></mixed-citation></ref><ref id="pone.0007733-Jak1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jak</surname><given-names>AJ</given-names></name><name><surname>Houston</surname><given-names>WS</given-names></name><name><surname>Nagel</surname><given-names>BJ</given-names></name><name><surname>Corey-Bloom</surname><given-names>J</given-names></name><name><surname>Bondi</surname><given-names>MW</given-names></name></person-group><year>2007</year><article-title>Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults.</article-title><source>Dement Geriatr Cogn Disord</source><volume>23</volume><fpage>382</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">17389798</pub-id></mixed-citation></ref><ref id="pone.0007733-Isoniemi1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isoniemi</surname><given-names>H</given-names></name><name><surname>Kurki</surname><given-names>T</given-names></name><name><surname>Tenovuo</surname><given-names>O</given-names></name><name><surname>Kairisto</surname><given-names>V</given-names></name><name><surname>Portin</surname><given-names>R</given-names></name></person-group><year>2006</year><article-title>Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury.</article-title><source>Neurology</source><volume>67</volume><fpage>756</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">16966535</pub-id></mixed-citation></ref><ref id="pone.0007733-Enzinger1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enzinger</surname><given-names>C</given-names></name><name><surname>Ropele</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Strasser-Fuchs</surname><given-names>S</given-names></name><name><surname>Poltrum</surname><given-names>B</given-names></name><etal/></person-group><year>2004</year><article-title>Accelerated evolution of brain atrophy and &#x0201c;black holes&#x0201d; in MS patients with APOE-epsilon 4.</article-title><source>Ann Neurol</source><volume>55</volume><fpage>563</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">15048896</pub-id></mixed-citation></ref><ref id="pone.0007733-Geroldi1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geroldi</surname><given-names>C</given-names></name><name><surname>Pihlajamaki</surname><given-names>M</given-names></name><name><surname>Laakso</surname><given-names>MP</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>Beltramello</surname><given-names>A</given-names></name><etal/></person-group><year>1999</year><article-title>APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.</article-title><source>Neurology</source><volume>53</volume><fpage>1825</fpage><lpage>1832</lpage><pub-id pub-id-type="pmid">10563634</pub-id></mixed-citation></ref><ref id="pone.0007733-Ho1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>KK</given-names></name><name><surname>Moody</surname><given-names>GB</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name><name><surname>Mietus</surname><given-names>JE</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><etal/></person-group><year>1997</year><article-title>Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics.</article-title><source>Circulation</source><volume>96</volume><fpage>842</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">9264491</pub-id></mixed-citation></ref><ref id="pone.0007733-Chiu1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>KM</given-names></name><name><surname>Chan</surname><given-names>HL</given-names></name><name><surname>Chu</surname><given-names>SH</given-names></name><name><surname>Lin</surname><given-names>TY</given-names></name></person-group><year>2007</year><article-title>Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure.</article-title><source>Auton Neurosci</source><volume>132</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17157564</pub-id></mixed-citation></ref><ref id="pone.0007733-Makikallio1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makikallio</surname><given-names>TH</given-names></name><name><surname>Koistinen</surname><given-names>J</given-names></name><name><surname>Jordaens</surname><given-names>L</given-names></name><name><surname>Tulppo</surname><given-names>MP</given-names></name><name><surname>Wood</surname><given-names>N</given-names></name><etal/></person-group><year>1999</year><article-title>Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts.</article-title><source>Am J Cardiol</source><volume>83</volume><fpage>880</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">10190403</pub-id></mixed-citation></ref><ref id="pone.0007733-Tapanainen1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapanainen</surname><given-names>JM</given-names></name><name><surname>Thomsen</surname><given-names>PE</given-names></name><name><surname>Kober</surname><given-names>L</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Makikallio</surname><given-names>TH</given-names></name><etal/></person-group><year>2002</year><article-title>Fractal analysis of heart rate variability and mortality after an acute myocardial infarction.</article-title><source>Am J Cardiol</source><volume>90</volume><fpage>347</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">12161220</pub-id></mixed-citation></ref><ref id="pone.0007733-Tsuji1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>H</given-names></name><name><surname>Venditti</surname><given-names>FJ</given-names><suffix>Jr</suffix></name><name><surname>Manders</surname><given-names>ES</given-names></name><name><surname>Evans</surname><given-names>JC</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><etal/></person-group><year>1994</year><article-title>Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.</article-title><source>Circulation</source><volume>90</volume><fpage>878</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">8044959</pub-id></mixed-citation></ref><ref id="pone.0007733-Yeh1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>GY</given-names></name><name><surname>Wood</surname><given-names>MJ</given-names></name><name><surname>Lorell</surname><given-names>BH</given-names></name><name><surname>Stevenson</surname><given-names>LW</given-names></name><name><surname>Eisenberg</surname><given-names>DM</given-names></name><etal/></person-group><year>2004</year><article-title>Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial.</article-title><source>Am J Med</source><volume>117</volume><fpage>541</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">15465501</pub-id></mixed-citation></ref><ref id="pone.0007733-Yeh2"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>GY</given-names></name><name><surname>Mietus</surname><given-names>JE</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name><name><surname>Phillips</surname><given-names>RS</given-names></name><name><surname>Davis</surname><given-names>RB</given-names></name><etal/></person-group><year>2008</year><article-title>Enhancement of sleep stability with Tai Chi exercise in chronic heart failure: preliminary findings using an ECG-based spectrogram method.</article-title><source>Sleep Med</source><volume>9</volume><fpage>527</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">17689142</pub-id></mixed-citation></ref><ref id="pone.0007733-Ghebremedhin1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Schultz</surname><given-names>C</given-names></name><name><surname>Thal</surname><given-names>DR</given-names></name><name><surname>Rub</surname><given-names>U</given-names></name><name><surname>Ohm</surname><given-names>TG</given-names></name><etal/></person-group><year>2001</year><article-title>Gender and age modify the association between APOE and AD-related neuropathology.</article-title><source>Neurology</source><volume>56</volume><fpage>1696</fpage><lpage>1701</lpage><pub-id pub-id-type="pmid">11425936</pub-id></mixed-citation></ref><ref id="pone.0007733-Mortensen1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortensen</surname><given-names>EL</given-names></name><name><surname>Hogh</surname><given-names>P</given-names></name></person-group><year>2001</year><article-title>A gender difference in the association between APOE genotype and age-related cognitive decline.</article-title><source>Neurology</source><volume>57</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11445633</pub-id></mixed-citation></ref><ref id="pone.0007733-Wenham1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenham</surname><given-names>PR</given-names></name><name><surname>Price</surname><given-names>WH</given-names></name><name><surname>Blandell</surname><given-names>G</given-names></name></person-group><year>1991</year><article-title>Apolipoprotein E genotyping by one-stage PCR.</article-title><source>Lancet</source><volume>337</volume><fpage>1158</fpage><lpage>1159</lpage><pub-id pub-id-type="pmid">1674030</pub-id></mixed-citation></ref><ref id="pone.0007733-Tsai1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>SJ</given-names></name><name><surname>Gau</surname><given-names>YT</given-names></name><name><surname>Liu</surname><given-names>ME</given-names></name><name><surname>Hsieh</surname><given-names>CH</given-names></name><name><surname>Liou</surname><given-names>YJ</given-names></name><etal/></person-group><year>2008</year><article-title>Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.</article-title><source>Neurosci Lett</source><volume>433</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">18242855</pub-id></mixed-citation></ref><ref id="pone.0007733-Yang1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>AC</given-names></name><name><surname>Tsai</surname><given-names>SJ</given-names></name><name><surname>Hong</surname><given-names>CJ</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name><name><surname>Hsieh</surname><given-names>CH</given-names></name><etal/></person-group><year>2008</year><article-title>Association between heart rate variability and cognitive function in elderly community-dwelling men without dementia: a preliminary report.</article-title><source>J Am Geriatr Soc</source><volume>56</volume><fpage>958</fpage><lpage>960</lpage><pub-id pub-id-type="pmid">18454763</pub-id></mixed-citation></ref><ref id="pone.0007733-Liu1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>HC</given-names></name><name><surname>Hong</surname><given-names>CJ</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Fuh</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>PN</given-names></name><etal/></person-group><year>1999</year><article-title>ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults.</article-title><source>Neurology</source><volume>53</volume><fpage>962</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">10496253</pub-id></mixed-citation></ref><ref id="pone.0007733-Hong1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>CJ</given-names></name><name><surname>Liu</surname><given-names>TY</given-names></name><name><surname>Liu</surname><given-names>HC</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Fuh</surname><given-names>JL</given-names></name><etal/></person-group><year>1996</year><article-title>Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population.</article-title><source>Neurology</source><volume>46</volume><fpage>1749</fpage><lpage>1751</lpage><pub-id pub-id-type="pmid">8649585</pub-id></mixed-citation></ref><ref id="pone.0007733-Hallman1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallman</surname><given-names>DM</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Saha</surname><given-names>N</given-names></name><name><surname>Sandholzer</surname><given-names>C</given-names></name><name><surname>Menzel</surname><given-names>HJ</given-names></name><etal/></person-group><year>1991</year><article-title>The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.</article-title><source>Am J Hum Genet</source><volume>49</volume><fpage>338</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">1867194</pub-id></mixed-citation></ref><ref id="pone.0007733-Myers1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>RH</given-names></name><name><surname>Schaefer</surname><given-names>EJ</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>D'Agostino</surname><given-names>R</given-names></name><name><surname>Ordovas</surname><given-names>JM</given-names></name><etal/></person-group><year>1996</year><article-title>Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.</article-title><source>Neurology</source><volume>46</volume><fpage>673</fpage><lpage>677</lpage><pub-id pub-id-type="pmid">8618665</pub-id></mixed-citation></ref><ref id="pone.0007733-Slooter1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slooter</surname><given-names>AJ</given-names></name><name><surname>Cruts</surname><given-names>M</given-names></name><name><surname>Kalmijn</surname><given-names>S</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><etal/></person-group><year>1998</year><article-title>Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.</article-title><source>Arch Neurol</source><volume>55</volume><fpage>964</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">9678314</pub-id></mixed-citation></ref><ref id="pone.0007733-Kuusisto1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Koivisto</surname><given-names>K</given-names></name><name><surname>Kervinen</surname><given-names>K</given-names></name><name><surname>Mykkanen</surname><given-names>L</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><etal/></person-group><year>1994</year><article-title>Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.</article-title><source>Br Med J</source><volume>309</volume><fpage>636</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">8086986</pub-id></mixed-citation></ref><ref id="pone.0007733-Goldberger3"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname><given-names>AL</given-names></name><name><surname>Amaral</surname><given-names>LA</given-names></name><name><surname>Glass</surname><given-names>L</given-names></name><name><surname>Hausdorff</surname><given-names>JM</given-names></name><name><surname>Ivanov</surname><given-names>PC</given-names></name><etal/></person-group><year>2000</year><article-title>PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals.</article-title><source>Circulation</source><volume>101</volume><fpage>E215</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">10851218</pub-id></mixed-citation></ref><ref id="pone.0007733-Mietus1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mietus</surname><given-names>JE</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name><name><surname>Henry</surname><given-names>I</given-names></name><name><surname>Goldsmith</surname><given-names>RL</given-names></name><name><surname>Goldberger</surname><given-names>AL</given-names></name></person-group><year>2002</year><article-title>The pNNx files: re-examining a widely used heart rate variability measure.</article-title><source>Heart</source><volume>88</volume><fpage>378</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">12231596</pub-id></mixed-citation></ref><ref id="pone.0007733-TaskForce1"><label>38</label><mixed-citation publication-type="journal"><collab>Task-Force</collab><year>1996</year><article-title>Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use.</article-title><source>Circulation</source><volume>93</volume><fpage>1043</fpage><lpage>1065</lpage><pub-id pub-id-type="pmid">8598068</pub-id></mixed-citation></ref><ref id="pone.0007733-Goldberger4"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname><given-names>JJ</given-names></name><name><surname>Challapalli</surname><given-names>S</given-names></name><name><surname>Tung</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>MA</given-names></name><name><surname>Kadish</surname><given-names>AH</given-names></name></person-group><year>2001</year><article-title>Relationship of heart rate variability to parasympathetic effect.</article-title><source>Circulation</source><volume>103</volume><fpage>1977</fpage><lpage>1983</lpage><pub-id pub-id-type="pmid">11306527</pub-id></mixed-citation></ref><ref id="pone.0007733-Katona1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katona</surname><given-names>PG</given-names></name><name><surname>Jih</surname><given-names>F</given-names></name></person-group><year>1975</year><article-title>Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control.</article-title><source>J Appl Physiol</source><volume>39</volume><fpage>801</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">1184518</pub-id></mixed-citation></ref><ref id="pone.0007733-Pomeranz1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomeranz</surname><given-names>B</given-names></name><name><surname>Macaulay</surname><given-names>RJ</given-names></name><name><surname>Caudill</surname><given-names>MA</given-names></name><name><surname>Kutz</surname><given-names>I</given-names></name><name><surname>Adam</surname><given-names>D</given-names></name><etal/></person-group><year>1985</year><article-title>Assessment of autonomic function in humans by heart rate spectral analysis.</article-title><source>Am J Physiol</source><volume>248</volume><fpage>H151</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">3970172</pub-id></mixed-citation></ref><ref id="pone.0007733-Malliani1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malliani</surname><given-names>A</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Pagani</surname><given-names>M</given-names></name></person-group><year>1994</year><article-title>Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms.</article-title><source>Br Heart J</source><volume>71</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">8297682</pub-id></mixed-citation></ref><ref id="pone.0007733-BarYam1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Yam</surname><given-names>Y</given-names></name></person-group><year>1997</year><article-title>Dynamics of complex systems: Westview Press.</article-title></mixed-citation></ref><ref id="pone.0007733-Costa1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>M</given-names></name><name><surname>Goldberger</surname><given-names>AL</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name></person-group><year>2002</year><article-title>Multiscale entropy analysis of complex physiologic time series.</article-title><source>Phys Rev Lett</source><volume>89</volume><fpage>068102</fpage><pub-id pub-id-type="pmid">12190613</pub-id></mixed-citation></ref><ref id="pone.0007733-Huang1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>NE</given-names></name><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Long</surname><given-names>SR</given-names></name><name><surname>Wu</surname><given-names>MLC</given-names></name><name><surname>Shih</surname><given-names>HH</given-names></name><etal/></person-group><year>1998</year><article-title>The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysis.</article-title><source>Proc R Soc London, Ser A</source><volume>454</volume><fpage>903</fpage><lpage>995</lpage></mixed-citation></ref><ref id="pone.0007733-Wu1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>NE</given-names></name><name><surname>Long</surname><given-names>SR</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name></person-group><year>2007</year><article-title>On the trend, detrending, and variability of nonlinear and nonstationary time series.</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>14889</fpage><lpage>14894</lpage><pub-id pub-id-type="pmid">17846430</pub-id></mixed-citation></ref><ref id="pone.0007733-Costa2"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>M</given-names></name><name><surname>Goldberger</surname><given-names>AL</given-names></name><name><surname>Peng</surname><given-names>CK</given-names></name></person-group><year>2005</year><article-title>Multiscale entropy analysis of biological signals.</article-title><source>Phys Rev E</source><volume>71</volume><fpage>021906</fpage></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants V95ER3-003, V96ER3-002, and V97ER3-003 from Taipei Veterans General Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>